Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2003
11/13/2003US20030211528 Exponential amplification of sub-picogram nucleic acid samples with retention of quantitative representation
11/13/2003US20030211527 Internal positive control for probe-based nucleic acid molecule assays and methods of making and using thereof
11/13/2003US20030211526 Cross-species nucleic acid probes
11/13/2003US20030211525 Comprise nucleotide sequences coding cell cycle protein for use in diagnosis, prognosis and treatment of cancer and autoimmune diseases
11/13/2003US20030211523 Using green fluorescent protein to detect polypeptide interactions in cells; high throughout assay
11/13/2003US20030211522 Methods for fetal DNA detection and allele quantitation
11/13/2003US20030211519 Identifying angiogenesis inhibitor for treating cell proliferative disorders; antitumor agents
11/13/2003US20030211516 Screening RNA molecules which bind preferential fluorescent agents which aid in detection, visualization, or quantitation of nucleic acids
11/13/2003US20030211515 Comprises nucleotide sequences coding matrix protein for diagnosing and treating cancer
11/13/2003US20030211513 Intracellular signaling proteins
11/13/2003US20030211512 Genotying swine for presence of restriction fragment length polymorphism in growth hormone (GH) secretagogue receptor which is associated with preferential growth, appetite and fatness; animal husbandry; veterinary medicine
11/13/2003US20030211510 For stimulating and/or expanding T cells specific for lung tumors diagnosis, prevention and/or treatment of diseases, particularly lung cancer
11/13/2003US20030211506 Comprises nucleotide sequences coding Bacillus endonuclease and modification methylase for propagating nucleotide sequences using strand displacement amplification
11/13/2003US20030211505 Using bioassays for detecting nucleotide sequences or polypeptides for diagnosis, prevention and treatment of respiratory disorders; organ transplantion
11/13/2003US20030211504 Methods for identifying nucleic acid polymorphisms
11/13/2003US20030211503 Using concentration of zinc finger protein (WT1) to detect cancer in children
11/13/2003US20030211502 Ultra-fast nucleic acid sequencing device and a method for making and using the same
11/13/2003US20030211500 Genetic diagnosis for qt prolongation related adverse drug reactions
11/13/2003US20030211499 Transporters and ion channels
11/13/2003US20030211498 Tumor markers in ovarian cancer
11/13/2003US20030211497 Diagnosis of schizohprenia by linkage of a polymorphic marker to a segment of chromosome 1q22 bordered by d1s2705 and d1s1679
11/13/2003US20030211496 Kit for calibrating solid supports/matrices associated with polynucleotide hybridization methodologies; genetic analysis
11/13/2003US20030211495 Identifying peptide that partially or completely inhibits interaction between two or more binding partners; competitive binding; high throughput assays; drug screening
11/13/2003US20030211494 Recovering nucleotide sequences coding amylases, aminocyclases and/or amidohydrolases; diagnostic tools
11/13/2003US20030211493 Comprises membrane protein for diagnosis, prevention and treatment of infections, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders
11/13/2003US20030211492 Using magnetic resonance imaging to identify and characterize nitroxide labeled nucleotide sequences
11/13/2003US20030211491 Method and marker for identification of pre-malignancy and malignancy and therapeutic intervention
11/13/2003US20030211489 Using gene probe assay to amplify and/or genotype a variety of nucleotide sequences samples simultaneously
11/13/2003US20030211488 Nanoparticle probs with Raman spectrocopic fingerprints for analyte detection
11/13/2003US20030211486 Compositions and methods for detecting polymorphisms associated with pigmentation
11/13/2003US20030211483 Methods for the enrichment of low-abundance polynucleotides
11/13/2003US20030211482 Using fluorescent dyes to detect point mutations in preferential nucleotide sequences; restriction fragment length polymorphisms
11/13/2003US20030211480 Molecular interaction assays on a solid surface
11/13/2003US20030211479 Method and apparatus for detecting DNA hybridization
11/13/2003US20030211478 Transcription factor profiling on a solid surface
11/13/2003US20030211475 Monitoring reporter gene expression/transcriptional activity in the ergosterol and protein kinase c pathway of cell; gene expression inhibition; antitumor agents; drug screening
11/13/2003US20030211474 Use of unstructured nucleic acids in assaying nucleic acid molecules
11/13/2003US20030211473 Cancer diagnostic method based upon DNA methylation differences
11/13/2003US20030211471 Method for detecting ligands and targets in a mixture
11/13/2003US20030211470 Comprises chimeric heterotetrameric heavy chain polypeptides (CD4-IgG2) for use in the prevention and treatment of viral diseases; immunoassay
11/13/2003US20030211469 Using geldanamycin or radicicol to prevent viral replication and infection; viricides
11/13/2003US20030211468 Comprises monoclonal antibody which deactivates kaposi's sarcoma associated herpesvirus interleukin-6 (KSRV VIL-6) for treating, diagnosing and prognosing oncogenic viral infections; antiarthritic agents; antitumor agents
11/13/2003US20030211467 Using monoclonal antibody for diagnosis, prevention and treatment of viral infections; immunotherapy; genetic vaccine
11/13/2003US20030211466 Using cells messenger RNA expression profile to diagnose infections or metabolic disorders
11/13/2003US20030211462 Directionally cloned random cDNA expression vector libraries, compositions and methods of use
11/13/2003US20030211458 Measurements of enzymatic activity in a single, individual cell in population
11/13/2003US20030211457 Methods and kits for testing mutagenicity
11/13/2003US20030211456 Method of profiling a plant extract
11/13/2003US20030211455 Methods and compositions for identifying ligands for nuclear receptors
11/13/2003US20030211109 Methods of modulating angiogenesis
11/13/2003US20030211105 Methods for reducing tumor growth and metastasis by inhibiting mcp-1 activity
11/13/2003US20030211101 Vascular endothelial growth factor-like protein from ORF viruses binds and activates mammalian VEGF receptor-2, and uses thereof
11/13/2003US20030211092 Genetic engineering; gene expression; culture product
11/13/2003US20030211090 Isolation culture product; cell differentiation
11/13/2003US20030211065 Alopecia; mutant gene
11/13/2003US20030211040 Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain
11/13/2003US20030211005 Methods and compositions for neutralizing anthrax and other bioagents
11/13/2003US20030209432 Methods and compositions relating to electrical detection of nucleic acid reactions
11/13/2003CA2652991A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
11/13/2003CA2524569A1 A method of regulating gene expression
11/13/2003CA2491708A1 Non-viral gene delivery system
11/13/2003CA2485099A1 Apparatus including ion transport detecting structures and methods of use
11/13/2003CA2485089A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/13/2003CA2485038A1 Transgenic animal model for spliceosome-mediated rna trans-splicing
11/13/2003CA2484920A1 Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression
11/13/2003CA2484730A1 Device and method for analytical cell imaging
11/13/2003CA2484600A1 Therapeutic use of selective pde10 inhibitors
11/13/2003CA2484499A1 Short enzyme donor fragment
11/13/2003CA2484187A1 Human adipocyte cell populations and methods for identifying modulators of same
11/13/2003CA2484153A1 Methods for discovering tumor biomarkers and diagnosing tumors
11/13/2003CA2483909A1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
11/13/2003CA2483585A1 Test strip and method for determining concentration of creatinine in a body fluid
11/13/2003CA2483047A1 Ice1, a regulator of cold induced transcriptome and freezing tolerance in plants
11/13/2003CA2482967A1 Binary or polynary targeting and uses thereof
11/13/2003CA2482812A1 Mitochondrial polymorphisms linked to a predisposition for the development of inappropriate scarring or fibrosis
11/13/2003CA2427386A1 Genotyping by amplicon melting curve analysis
11/12/2003EP1361436A1 Multilayer reagent test strips and methods for using the same to quantify glycated protein in a physiological sample
11/12/2003EP1361433A2 Method for estimating therapeutic efficacy of tumor necrosis factor (TNF)
11/12/2003EP1361426A1 Method of detecting substance inhibiting type iii secretion mechanism of bacterium and the function of secretory protein thereof
11/12/2003EP1361286A1 Method for detection of cancer
11/12/2003EP1361285A2 Protein kinase peptide substrate determination using peptide libraries
11/12/2003EP1361284A1 Process for generating sequence-specific proteases by directed evolution and use thereof
11/12/2003EP1361283A1 Novel assay method
11/12/2003EP1361282A1 Method and apparatus for immediately discriminating microorganism
11/12/2003EP1361275A1 Cloned DNA polymerases from thermotoga neapolitana and mutants thereof
11/12/2003EP1361270A2 Disruption of the REDK gene
11/12/2003EP1361229A2 Use of Tyrosine Kinase (PYK2) to produce antibodies
11/12/2003EP1361228A1 Thermostable and monoconjugatable gold cluster complexes
11/12/2003EP1360965A1 Methods of treating diseases in association with decrease in the expression of aop-1 gene or aop-1 and remedies for the diseases
11/12/2003EP1360504A2 Method for screening compounds for activity in treating an osteoclast related bone disease
11/12/2003EP1360501A2 Method of identifying conformation-sensitive binding peptides and uses thereof
11/12/2003EP1360500A2 Methods for selective targeting
11/12/2003EP1360498A2 Latent human tuberculosis model, diagnostic antigens, and methods of use
11/12/2003EP1360496A1 Methods and reagents for the rapid and efficient isolation of circulating cancer cells
11/12/2003EP1360495A2 High throughput screening of compounds for biological activity
11/12/2003EP1360493A1 Screening method using solid supports modified with self-assembled monolayers
11/12/2003EP1360489A1 Low affinity screening method
11/12/2003EP1360488A1 Spatially resolved enzyme-linked assay
11/12/2003EP1360486A2 Screening method for identifying compounds that selectively induce interferon alpha
11/12/2003EP1360484A1 Enzymatic test for the determination of the risk of pathologies related to the presence of sialidase or prolidase activity in women body fluid samples
1 ... 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 ... 3003